FDA Announces Voluntary Recall of EpiPen and EpiPen Jr

13 lots of Mylan products are being voluntarily recalled.

Apr 04, 2017

The Food and Drug Administration is alerting consumers to Meridian Medical Technologies' voluntary recall of 13 lots of Mylan's EpiPen and EpiPen Jr. Auto-Injector products. The products may contain a defective part that could result in a failure to activate.

The 13 identified lots were distributed between Dec. 17, 2015, and July 1, 2016, and they are the only lots affected by the U.S. recall. "Consumers who have EpiPens from lots that are not included in this recall, do not need to replace their EpiPen prior to its expiration date," according to the agency's notice.

It said that, "while the number of reported failures is small, EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes untreated. Consumers should keep and use their current EpiPens if needed until they get a replacement. Consumers should contact Mylan at 800-796-9526 or customer.service@mylan.com with any questions."

Get the latest on trends you can expect to hear more about in 2019, including continued growth of mobile safety applications, wearable technology, and smart PPE; autonomous vehicles; pending OSHA recordkeeping rulemaking; and increased adoption of international safety standard, ISO 45001.

When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common training questions.

Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.